Jefferies Group LLC Cara Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 13, 2019	SELL	$18.28 - $26.91 $36,560 - $53,820	-2,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $91,936 - $112,164	-5,200 Reduced 72.22%	2,000 $43,000
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $103,752 - $141,408	7,200 New	7,200 $141,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $1.29 Million - $2.43 Million	-103,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $1.82 Million - $2.48 Million	103,600 New	103,600 $2.48 Million

826K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $257M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.